Published: 07:37 AM, 24 August 2020
Janomot report: The overall number of global coronavirus cases has topped 23.3 million, while the deaths have increased to over 807,000, according to the Johns Hopkins University.
As of Monday morning, the total number of cases stood at 23,348,081 and the fatalities rose to 807,383, the University’s Center for Systems Science and Engineering (CSSE) revealed in its latest update.
The US accounted for the world’s highest number of cases and deaths at 5,701,557 and 176,797, respectively, according to the CSSE.
Brazil came in the second place with 3,605,783 infections and 114,744 deaths.
In terms of cases, India ranks third (3,044,940), and is followed by Russia (954,328), South Africa (609,773), Peru (585,236), Mexico (560,164), Colombia (533,103), Chile (397,665), Spain (386,054), Iran (358,905), Argentina (342,154), the UK (327,643), Saudi Arabia (307,479), Bangladesh (294,598), Pakistan (292,765), France (280,459), Italy (259,345), Turkey (258,249), Germany (234,494), Iraq (204,341), Philippines (189,601), Indonesia (153,535), Canada (126,815), Qatar (117,008), Bolivia (108,427), Ecuador (107,769), Ukraine (107,379), Kazakhstan (104,543) and Israel (102,663), the CSSE figures showed.
The other countries with over 10,000 deaths are the Mexico (60,480), India (56,706), UK (41,515), Italy (35,437), France (30,518), Spain (28,838), Peru (27,453), Iran (20,643), Russia (16,341), Colombia (16,968), South Africa (13,059) and Chile (10,852).
Plasma Therapy in US
The U.S. Food and Drug Administration (FDA) issued an emergency use authorisation (EUA) on Sunday for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients, reports Xinhua.
It is part of the agency's ongoing efforts to fight COVID-19.
Based on scientific evidence available, the FDA concluded this product may be effective in treating COVID-19 and that the known and potential benefits of the product outweigh the known and potential risks of the product, said a release of the agency.
The EUA authorizes the distribution of COVID-19 convalescent plasma in the United States and its administration by healthcare providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in hospitalised patients with COVID-19, said the FDA.
Vaccine in China
A Chinese health official Saturday confirmed the country authorized emergency usage of COVID-19 vaccines developed by some select domestic companies on July 22, reports CCTV.
An emergency use authorization, which is based on Chinese vaccine management law, allows unapproved vaccine candidates to be used among people who are at high risk of getting infected on a limited period
By first inoculating the special groups, like frontline medical workers and civil servants, the move is to ensure that a city can keep normal functions when a health crisis strikes, the law stated.
Similar authorisations have been legalised in many countries. For example, U.S. Food and Drug Administration allows unapproved medical products to be used in an emergency to diagnose, treat or prevent life-threatening disease or conditions.
The national agency has used several emergency use authorisations since the coronavirus outbreak as a way to get many diagnostic tests more quickly to the market than the normal procedures.
According to China's National Medical Products Administration, at least eight potential coronavirus vaccines have entered different stages of clinical trials, reports CCTV.
In an interview with CCTV, Yang Xiaoming, chief scientist of China's vaccine development and CEO of China National Biotec Group (CNBG) said they've signed agreements with many countries on inactivated vaccine clinical trials over the past few months.
Coronavirus Situation in Bangladesh
Health authorities in Bangladesh on Sunday reported 1,973 new Covid-19 cases in 24 hours, which was the lowest since August 4 when 1,918 cases were detected across the country.
With the latest ones, the total number of Covid-19 cases in the country jumped to 2,94,598 in the 24th week of the first virus detection.
Meanwhile, the death toll from the disease rose to 3,941 as 34 more patients succumbed to the disease in the last 24 hours.